GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.327 15 days ( 10.43 % )
Last Price $8.85 2.08 %
High/ Low $8.65 - $8.98 -1.16%
Chg 7 Days -4.32 % $9.25 $8.85
Chg 30 Days -17.67 % $10.75 $8.85
Chg 12 mos -9.97 % $9.83 $8.85
Trend - 3 mos -15.41 % Width: 34.73 %
Trend - 12 mos 29.00 % Width: 70.56 %
Pred. range - 3 mos $7.30 - $9.84 -17.46 % - 11.21 %
Pred. range - 12 mos $10.09 - $17.21 14.04 % - 94.50 %
Short MA avg 3 mos Buy 2024-03-27 - 17 days
Long MA avg 3 mos Sell 2024-03-08 - 30 days
Short/Long MA avg 3 mos Sell 2024-03-12 - 28 days
Short MA avg 12 mos Sell 2024-03-06 - 32 days
Long MA avg 12 mos Sell 2024-03-28 - 16 days
Short/Long MA avg 12 mos Sell 2024-04-08 - 10 days
Pivot Short Buy 2024-04-18 - 2 days
Bollinger Buy 2024-03-13 - 27 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Zymeworks Inc

Zymeworks Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ... ZYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT